Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1983 Jan;110(1):48–54.

Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).

A P Aguas, P A Nickerson
PMCID: PMC1916138  PMID: 6849371

Abstract

The effect of verapamil, a calcium antagonist, was studied in rats treated with deoxycorticosterone (DOC). DOC induced hypertensive cardiovascular disease with accompanying gross and microscopic lesions in heart and kidney. Verapamil administered in the drinking fluid (1% sodium chloride) prevented hypertension and significantly ameliorated the incidence and severity of cardiovascular lesions. With exception of the spleen, verapamil did not prevent renal or myocardial hypertrophy in rats treated with DOC in spite of prevention of hypertension. The level of verapamil in the serum of animals consuming verapamil (0.37 +/- 0.16 microgram/ml) was less than that of the DOC-verapamil group (0.89 +/- 0.16 microgram/ml), although the difference was not significant. These results confirm the efficacy of verapamil in reducing blood pressure and in ameliorating vascular lesions.

Full text

PDF
48

Images in this article

51Figure 1
on p.51
52Figure 2
on p.52
52Figure 3
on p.52
53Figure 4
on p.53

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki K., Ikeda N., Yamashita K., Tazumi K., Sato I. Cardiovascular contraction in spontaneously hypertensive rat: Ca2+ interaction of myofibrils and subcellular membrane of heart and arterial smooth muscle. Jpn Circ J. 1974 Dec;38(12):1115–1121. doi: 10.1253/jcj.38.1115. [DOI] [PubMed] [Google Scholar]
  2. Baginski E. S., Marie S. S., Clark W. L., Zak B. Direct microdetermination of serum calcium. Clin Chim Acta. 1973 Jun 14;46(1):49–54. doi: 10.1016/0009-8981(73)90101-0. [DOI] [PubMed] [Google Scholar]
  3. Beilin L. J., Goldby F. S., Mohring J. High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension. Clin Sci Mol Med. 1977 Feb;52(2):111–117. doi: 10.1042/cs0520111. [DOI] [PubMed] [Google Scholar]
  4. Blaustein M. P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977 May;232(5):C165–C173. doi: 10.1152/ajpcell.1977.232.5.C165. [DOI] [PubMed] [Google Scholar]
  5. Borgers M., Thoné F., van Nueten J. M. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique. Acta Histochem Suppl. 1981;24:327–332. [PubMed] [Google Scholar]
  6. Brittinger W. D., Schwarzbeck A., Wittenmeier K. W., Twittenhoff W. D., Stegaru B., Huber W., Ewald R. W., von Henning G. E., Fabricius M., Strauch M. Klinisch-experimentelle Untersuchungen über die blutdrucksenkende Wirkung von Verapamil. Dtsch Med Wochenschr. 1970 Sep 11;95(37):1871–1877. doi: 10.1055/s-0028-1108744. [DOI] [PubMed] [Google Scholar]
  7. Brownie A. C., Gallant S., Nickerson P. A., Joseph L. M. The occurrence of 11-deoxycorticosterone (DOC)-induced hypertension in the Long-Evans rat. Endocr Res Commun. 1978;5(1):71–80. doi: 10.1080/07435807809073637. [DOI] [PubMed] [Google Scholar]
  8. Canessa M., Adragna N., Solomon H. S., Connolly T. M., Tosteson D. C. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med. 1980 Apr 3;302(14):772–776. doi: 10.1056/NEJM198004033021403. [DOI] [PubMed] [Google Scholar]
  9. Colby H. D., Skelton F. R., Brownie A. C. Metopirone-induced hypertension in the rat. Endocrinology. 1970 Mar;86(3):620–628. doi: 10.1210/endo-86-3-620. [DOI] [PubMed] [Google Scholar]
  10. DAHL L. K., HEINE M., TASSINARI L. EFFECTS OF CHRONIC EXCESS SALT INGESTION. ROLE OF GENETIC FACTORS IN BOTH DOCA-SALT AND RENAL HYPERTENSION. J Exp Med. 1963 Oct 1;118:605–617. doi: 10.1084/jem.118.4.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Epstein S. E., Rosing D. R. Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation. 1981 Sep;64(3):437–441. doi: 10.1161/01.cir.64.3.437. [DOI] [PubMed] [Google Scholar]
  12. Hall C. E., Ayachi S., Hall O. Arthritis and other sequelae to intraperitoneally administered dextran in rats--relationship to molecular weight of the glucan. Tex Rep Biol Med. 1971 Fall;29(3):289–312. [PubMed] [Google Scholar]
  13. Hyde P. M., Daigneault E. A. Adrenal plasma levels of corticosterone and deoxycorticosterone in methylandrostenediol-salt induced hypertension (1). Steroids. 1968 Jun;11(6):721–731. doi: 10.1016/s0039-128x(68)80089-3. [DOI] [PubMed] [Google Scholar]
  14. Iriuchijima J., Numao Y., Suga H. Hemodynamics of experimentally hypertensive rats in conscious and anesthetized states. Jpn Heart J. 1976 Jan;17(1):80–87. doi: 10.1536/ihj.17.80. [DOI] [PubMed] [Google Scholar]
  15. Kuwajima I., Ueda K., Kamata C., Matsushita S., Kuramoto K., Murakami M., Hada Y. A study on the effects of nifedipine in hypertensive crises and severe hypertension. Jpn Heart J. 1978 Jul;19(4):455–467. doi: 10.1536/ihj.19.455. [DOI] [PubMed] [Google Scholar]
  16. Massingham R., Shevde S. The ionic composition of aortic smooth muscle from A.S.-hypertensive rats. Br J Pharmacol. 1973 Feb;47(2):422–424. doi: 10.1111/j.1476-5381.1973.tb08340.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McAllister R. G., Howell S. M. Fluorometric assay of verapamil in biological fluids and tissues. J Pharm Sci. 1976 Mar;65(3):431–432. doi: 10.1002/jps.2600650330. [DOI] [PubMed] [Google Scholar]
  18. Molteni A., Brownie A. C., Skelton F. R. Production of hypertensive vascular disease in the rat by methyltestosterone. Lab Invest. 1969 Aug;21(2):129–137. [PubMed] [Google Scholar]
  19. Nayler W. G., Szeto J. Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. Cardiovasc Res. 1972 Mar;6(2):120–128. doi: 10.1093/cvr/6.2.120. [DOI] [PubMed] [Google Scholar]
  20. Nickerson P. A., Conran R. M. Parathyroidectomy ameliorates vascular lesions induced by deoxycorticosterone in the rat. Am J Pathol. 1981 Nov;105(2):185–190. [PMC free article] [PubMed] [Google Scholar]
  21. Olivari M. T., Bartorelli C., Polese A., Fiorentini C., Moruzzi P., Guazzi M. D. Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation. 1979 May;59(5):1056–1062. doi: 10.1161/01.cir.59.5.1056. [DOI] [PubMed] [Google Scholar]
  22. Opie L. H. Drugs and the heart. III. Calcium antagonists. Lancet. 1980 Apr 12;1(8172):806–810. doi: 10.1016/s0140-6736(80)91303-3. [DOI] [PubMed] [Google Scholar]
  23. Rapp J. P. Deoxycorticosterone production in adrenal regeneration hypertension: in vitro vs. in vivo comparison. Endocrinology. 1969 Jun;84(6):1409–1420. doi: 10.1210/endo-84-6-1409. [DOI] [PubMed] [Google Scholar]
  24. Rosing D. R., Kent K. M., Borer J. S., Seides S. F., Maron B. J., Epstein S. E. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation. 1979 Dec;60(6):1201–1207. doi: 10.1161/01.cir.60.6.1201. [DOI] [PubMed] [Google Scholar]
  25. Rosing D. R., Kent K. M., Maron B. J., Condit J., Epstein S. E. Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy. Chest. 1980 Jul;78(1 Suppl):239–247. doi: 10.1378/chest.78.1_supplement.239. [DOI] [PubMed] [Google Scholar]
  26. Schamroth L., Krikler D. M., Garrett C. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J. 1972 Mar 11;1(5801):660–662. doi: 10.1136/bmj.1.5801.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schamroth L. The clinical use of intravenous verapamil. Am Heart J. 1980 Dec;100(6 Pt 2):1070–1075. doi: 10.1016/0002-8703(80)90215-x. [DOI] [PubMed] [Google Scholar]
  28. Singh B. N., Ellrodt G., Peter C. T. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs. 1978 Mar;15(3):169–197. doi: 10.2165/00003495-197815030-00001. [DOI] [PubMed] [Google Scholar]
  29. Smith H. J., Singh B. N., Norris R. M., Nisbet H. D., John M. B., Hurley P. J. The effect of verapamil on experimental myocardial ischaemia with a particular reference to regional myocardial blood flow and metabolism. Aust N Z J Med. 1977 Apr;7(2):114–121. doi: 10.1111/j.1445-5994.1977.tb04676.x. [DOI] [PubMed] [Google Scholar]
  30. Tobian L., Chesley G. Calcium content of arteriolar walls in normotensive and hypertensive rats. Proc Soc Exp Biol Med. 1966 Feb;121(2):340–343. doi: 10.3181/00379727-121-30773. [DOI] [PubMed] [Google Scholar]
  31. Tomanek R. J. The role of prevention or relief of pressure overload on the myocardial cell of the spontaneously hypertensive rat: a morphometric and stereologic study. Lab Invest. 1979 Jan;40(1):83–91. [PubMed] [Google Scholar]
  32. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  33. Wambach G., Higgins J. R. Antihypertensive effect of progesterone in rats with mineralocorticoid-induced hypertension. Am J Physiol. 1979 Apr;236(4):E366–E370. doi: 10.1152/ajpendo.1979.236.4.E366. [DOI] [PubMed] [Google Scholar]
  34. Wei J. W., Janis R. A., Daniel E. E. Calcium accumulation and enzymatic activities of subcellular fractions from aortas and ventricles of genetically hypertensive rats. Circ Res. 1976 Jul;39(1):133–140. doi: 10.1161/01.res.39.1.133. [DOI] [PubMed] [Google Scholar]
  35. Zsotér T. T., Wolchinsky C., Henein N. F., Ho L. C. Calcium kinetics in the aorta of spontaneously hypertensive rats. Cardiovasc Res. 1977 Jul;11(4):353–357. doi: 10.1093/cvr/11.4.353. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES